Goserelin
FDA-approved GnRH (the brain's master reproductive-hormone signal) implant medicine — labeled cancer and hormone uses.
What it's for
Goserelin is a GnRH (the brain's master reproductive-hormone signal) medicine given as an under-the-skin implant. It first stimulates, then quiets, the reproductive hormone control loop. Approved uses include certain prostate and breast cancer settings and other labeled hormone-related conditions.
What it does for the body
Approved uses include certain prostate and breast cancer settings and other labeled hormone-related conditions. Exact uses depend on the product label. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
It acts on the brain-pituitary reproductive control switch. After an early surge, ongoing use lowers sex-hormone signals. Think of holding down a reset button on the hormone thermostat.
Research context
Bottom line for readers: Goserelin has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Sexual research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Goserelin — FDA.gov search
- ClinicalTrials.gov search: Goserelin — U.S. clinical trials registry
- Drugs@FDA search: Goserelin — FDA drug database (if approved)
- PubMed search: Goserelin — NCBI PubMed
- PubMed Central search: Goserelin — NCBI PMC